Skip to main content
SpringerLink
Log in

Hépatite aiguë cytolytique induite par l’allopurinol chez un patient traité pour hépatite virale C

Acute cytolytic hepatitis induced by allopurinol in a patient treated for hepatitis C

  • Cas Clinique / Case Report
  • Published:
Journal Africain d'Hépato-Gastroentérologie

Résumé

L’allopurinol est un inhibiteur de la synthèse de l’acide urique indiqué dans le traitement des hyperuricémies. Sa toxicité hépatique est rare. Nous rapportons un cas d’hépatite aiguà la prise d’allopurinol chez un patient agé de 65 ans sous bithérapie pour hépatite virale C.

Abstract

Allopurinol is a drug indicated for the treatment of hyperuricemia. Its hepatic toxicity is rare. This is a case report about acute cytolytic hepatitis caused by allopurinol in a 65-year-old patient undergoing dual therapy for hepatitis C.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Références

  1. Agence française de sécurité sanitaire des produits de santé (1999) Réactions cutanées et syndromes d’hypersensibilité liés à l’allopurinol

  2. Biour M, Poupon R, Grangé JD, Chazouillères O (2000) Hépatotoxicité des médicaments: 13e mise à jour du fichier bibliographique des atteintes hépatiques et des médicaments responsables. Gastroenterol Clin Biol 24:1052–1091

    PubMed  CAS  Google Scholar 

  3. Chalasani N, Fontana RJ, Bonkovsky HL, et al (2008) Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States. Gastroenterology 135:1924–1934

    Article  PubMed  Google Scholar 

  4. Watkins PB, Seef LB (2006) Drug-induced liver injury: summary of a single topic clinical research conference. Hepatology 43:618–631

    Article  PubMed  Google Scholar 

  5. Mallat A (1999) Hépatites médicamenteuses: diagnostic et prise en charge. Cahiers FMC. Gastroenterol Clin Biol 23:906–914

    PubMed  CAS  Google Scholar 

  6. Mallat A (1999) Hépatites médicamenteuses: revue bibliographique. Cahiers FMC. Gastroenterol Clin Biol 23:921–925

    Google Scholar 

  7. Pessayre D (1995) Mécanismes des hépatites médicamenteuses. Une conséquence de la superposition de deux systèmes xénophobes. Gastroenterol Clin Biol 19:B47–B56

    PubMed  CAS  Google Scholar 

  8. Ingelman-Sundberg M (2008) Pharmacogenomic biomarkers for prediction of severe adverse drug reactions. N Engl J Med 358:637–639

    Article  PubMed  CAS  Google Scholar 

  9. Entretien avec le Professeur Dhumeaux: atteintes hépatiques d’origines médicamenteuses. Cahiers FMC. Gastroenterol Clin Biol 1999; 23:917–920

  10. Andrade RJ, Lucena MI, Fernandez MC, et al (2005) Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period. Gastroenterology 129:512–521

    PubMed  Google Scholar 

  11. Danan G (2003) Atteintes hépatiques aiguës médicamenteuses. Qu’apportent les échelles diagnostiques ? Gastroenterol Clin Biol 27:B21–B25

    PubMed  Google Scholar 

  12. Rochon J, Protiva P, Seeff LB, et al (2008) Reliability of the Roussel Uclaf Causality Assessment Method for assessing causality in drug-induced liver injury. Hepatology 48(4):1175–1183

    Article  PubMed  Google Scholar 

  13. Durand F, Bernuau J, Pessayre D (1998) Hépatotoxicité des médicaments antituberculeux: implications pratiques pour la surveillance. Gastroenterol Clin Biol 22:117–120

    PubMed  CAS  Google Scholar 

  14. Dhumeaux D, Mallat A (1993) Hépatites chroniques et cirrhoses d’origine médicamenteuse. Gastroenterol Clin Biol 17:H31–H35

    PubMed  CAS  Google Scholar 

  15. Ganne-Carrie N, DeLeusse A, Guettier C, et al (1998) Hépatites d’allure auto-immune induites par les fibrates. Gastroenterol Clin Biol 22:525–529

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. 19, rue Oued-El-Makhazine, appartement no7, Agdal, Rabat, Maroc

    M. Tamzaourte

  2. Clinique médicale B, CHU Ibn-Sina, Rabat, Maroc

    M. Tamzaourte, I. Errabih, H. Krami, L. Ouazzani, N. Benzzoubeir, M. Fadlouallah, M. Lahmiri, G. Kharrasse, S. Tahri, H. Elkoundi & H. Ouazzani

Authors
  1. M. Tamzaourte
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. I. Errabih
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. H. Krami
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. L. Ouazzani
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. N. Benzzoubeir
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. M. Fadlouallah
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. M. Lahmiri
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. G. Kharrasse
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. S. Tahri
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. H. Elkoundi
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. H. Ouazzani
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M. Tamzaourte.

About this article

Cite this article

Tamzaourte, M., Errabih, I., Krami, H. et al. Hépatite aiguë cytolytique induite par l’allopurinol chez un patient traité pour hépatite virale C. J Afr Hepato Gastroenterol 3, 160–162 (2009). https://doi.org/10.1007/s12157-009-0102-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12157-009-0102-0

Mots clés

Keywords

Search

Navigation